CD25bright NK cells display superior function and metabolic activity under regulatory T cell-mediated suppression

Infusion of natural killer (NK) cells is an attractive therapeutic modality in patients with cancer. However, the activity of NK cells is regulated by several mechanisms operating within solid tumors. Regulatory T (Treg) cells suppress NK cell activity through various mechanisms including deprivatio...

Full description

Saved in:
Bibliographic Details
Main Authors: Ziqing Chen, Le Tong, Shi Yong Neo, Shuijie Li, Jiwei Gao, Susanne Schlisio, Andreas Lundqvist
Format: Article
Language:English
Published: Taylor & Francis Group 2023-12-01
Series:OncoImmunology
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/2162402X.2023.2175517
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850035429950095360
author Ziqing Chen
Le Tong
Shi Yong Neo
Shuijie Li
Jiwei Gao
Susanne Schlisio
Andreas Lundqvist
author_facet Ziqing Chen
Le Tong
Shi Yong Neo
Shuijie Li
Jiwei Gao
Susanne Schlisio
Andreas Lundqvist
author_sort Ziqing Chen
collection DOAJ
description Infusion of natural killer (NK) cells is an attractive therapeutic modality in patients with cancer. However, the activity of NK cells is regulated by several mechanisms operating within solid tumors. Regulatory T (Treg) cells suppress NK cell activity through various mechanisms including deprivation of IL-2 via the IL-2 receptor alpha (CD25). Here, we investigate CD25 expression on NK cells to confer persistence in Treg cells containing solid tumor models of renal cell carcinoma (RCC). Compared with IL-2, stimulation with IL-15 increases the expression of CD25 resulting in enhanced response to IL-2 as evidenced by increased phosphorylation of STAT5. Compared with CD25dim NK cells, CD25bright NK cells isolated from IL-15 primed NK cells display increased proliferative and metabolic activity as well as increased ability to persist in Treg cells containing RCC tumor spheroids. These results support strategies to enrich for or selectively expand CD25bright NK cells for adoptive cellular therapy of NK cells.
format Article
id doaj-art-e02799ceb39a4ea993f8747d63d70183
institution DOAJ
issn 2162-402X
language English
publishDate 2023-12-01
publisher Taylor & Francis Group
record_format Article
series OncoImmunology
spelling doaj-art-e02799ceb39a4ea993f8747d63d701832025-08-20T02:57:29ZengTaylor & Francis GroupOncoImmunology2162-402X2023-12-0112110.1080/2162402X.2023.2175517CD25bright NK cells display superior function and metabolic activity under regulatory T cell-mediated suppressionZiqing Chen0Le Tong1Shi Yong Neo2Shuijie Li3Jiwei Gao4Susanne Schlisio5Andreas Lundqvist6Department of Oncology-Pathology, Karolinska Institutet, Stockholm, SwedenDepartment of Oncology-Pathology, Karolinska Institutet, Stockholm, SwedenDepartment of Oncology-Pathology, Karolinska Institutet, Stockholm, SwedenDepartment of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, SwedenDepartment of Oncology-Pathology, Karolinska Institutet, Stockholm, SwedenDepartment of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, SwedenDepartment of Oncology-Pathology, Karolinska Institutet, Stockholm, SwedenInfusion of natural killer (NK) cells is an attractive therapeutic modality in patients with cancer. However, the activity of NK cells is regulated by several mechanisms operating within solid tumors. Regulatory T (Treg) cells suppress NK cell activity through various mechanisms including deprivation of IL-2 via the IL-2 receptor alpha (CD25). Here, we investigate CD25 expression on NK cells to confer persistence in Treg cells containing solid tumor models of renal cell carcinoma (RCC). Compared with IL-2, stimulation with IL-15 increases the expression of CD25 resulting in enhanced response to IL-2 as evidenced by increased phosphorylation of STAT5. Compared with CD25dim NK cells, CD25bright NK cells isolated from IL-15 primed NK cells display increased proliferative and metabolic activity as well as increased ability to persist in Treg cells containing RCC tumor spheroids. These results support strategies to enrich for or selectively expand CD25bright NK cells for adoptive cellular therapy of NK cells.https://www.tandfonline.com/doi/10.1080/2162402X.2023.2175517Natural killer cellsregulatory T cellsIL-15CD25tumor microenvironment
spellingShingle Ziqing Chen
Le Tong
Shi Yong Neo
Shuijie Li
Jiwei Gao
Susanne Schlisio
Andreas Lundqvist
CD25bright NK cells display superior function and metabolic activity under regulatory T cell-mediated suppression
OncoImmunology
Natural killer cells
regulatory T cells
IL-15
CD25
tumor microenvironment
title CD25bright NK cells display superior function and metabolic activity under regulatory T cell-mediated suppression
title_full CD25bright NK cells display superior function and metabolic activity under regulatory T cell-mediated suppression
title_fullStr CD25bright NK cells display superior function and metabolic activity under regulatory T cell-mediated suppression
title_full_unstemmed CD25bright NK cells display superior function and metabolic activity under regulatory T cell-mediated suppression
title_short CD25bright NK cells display superior function and metabolic activity under regulatory T cell-mediated suppression
title_sort cd25bright nk cells display superior function and metabolic activity under regulatory t cell mediated suppression
topic Natural killer cells
regulatory T cells
IL-15
CD25
tumor microenvironment
url https://www.tandfonline.com/doi/10.1080/2162402X.2023.2175517
work_keys_str_mv AT ziqingchen cd25brightnkcellsdisplaysuperiorfunctionandmetabolicactivityunderregulatorytcellmediatedsuppression
AT letong cd25brightnkcellsdisplaysuperiorfunctionandmetabolicactivityunderregulatorytcellmediatedsuppression
AT shiyongneo cd25brightnkcellsdisplaysuperiorfunctionandmetabolicactivityunderregulatorytcellmediatedsuppression
AT shuijieli cd25brightnkcellsdisplaysuperiorfunctionandmetabolicactivityunderregulatorytcellmediatedsuppression
AT jiweigao cd25brightnkcellsdisplaysuperiorfunctionandmetabolicactivityunderregulatorytcellmediatedsuppression
AT susanneschlisio cd25brightnkcellsdisplaysuperiorfunctionandmetabolicactivityunderregulatorytcellmediatedsuppression
AT andreaslundqvist cd25brightnkcellsdisplaysuperiorfunctionandmetabolicactivityunderregulatorytcellmediatedsuppression